Viridian Therapeutics, Inc. (VRDN) Q4 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the Vivid Seats fourth quarter 2024 earnings conference call. Following management's prepared remarks, we will open the call for Q&A. I would now like to turn the call over to Kate Africk. Good morning, and welcome to Vivid Seats fourth quarter and full year 2024 earnings conference call. I'm Kate Africk, head of investor relations at Vivid Seats. Joining me today to discuss VividSeats results are Stan Chia, Chief Executive Officer, and Larry Fay, Chief Financial Officer. By now, everyone should have access to our fourth quarter earnings press release, which we released earlier this morning. The press release, as well as supplemental earnings slides, are available on the Investor Relations page of VividSeats' website at investors.vividseats.com. During the course of today's call, management may make forward-looking statements within the meaning of federal securities laws. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, including the risks and uncertainties described in our earnings press release, our most recent annual report on Form 10-K, and our other filings with the SEC. On today's call, we will refer to adjusted EBITDA, cash generation, and last 12 months net leverage, which are non-GAAP financial measures that provide useful information for our investors. To the extent reasonably available, a reconciliation of these non-GAAP financial measures to their comparable GAAP measures can be found in our earnings press release and supplemental earnings slides. And now, I would like to turn the call over to Stan. Good morning, everyone, and thank you for joining us today. As we reflect on 2024, We are encouraged by the performance of our investments that continue t...